As of 2026-03-15, the Fair Value of Akebia Therapeutics Inc (AKBA) is -0.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.46 USD, the upside of Akebia Therapeutics Inc is -134.49%.
With the market price of 1.46 USD and our fair value calculation, Akebia Therapeutics Inc (AKBA) is not a good investment. Investing in AKBA stocks now will result in a potential loss of 134.49%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -282.00 | -94.20 | -51.92 | -69.41 | -5.34 | -100.58 |
| YoY growth | 26.72% | 66.60% | 44.88% | -33.67% | 92.30% | 39.36% |
| Market Cap (mil) | 387.44 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | 39.36% |
| TTM earnings | -5.34 |